遠隔患者モニタリング市場 / RPM市場：製品別（ソフトウェア、サービス、デバイス、循環器、神経、血圧モニター、新生児、体重、体温、神経）、エンドユーザー別（プロバイダー、病院、診療所、在宅医療、患者、支払者）、地域別 - 2028年までの世界予測

Remote Patient Monitoring Market / RPM Market by Product (Software, Services, Devices, Cardiology, Neurological, BP Monitors, Neonatal, Weight, Temperature, Neuro), End user (Providers, Hospitals, Clinics, Home care, Patients, Payers) & Region - Global Forecast to 2028

世界の遠隔患者モニタリング市場は、2023年の140億米ドルから2028年には417億米ドルに達し、2023年から2028年の年平均成長率は20.1％になると予測されている。高齢者人口の増加、医療アクセスの拡大ニーズの高ま... もっと見る

出版社	出版年月	電子版価格	ページ数	図表数	言語
MarketsandMarkets マーケッツアンドマーケッツ	2023年11月7日	US$4,950 シングルユーザライセンスライセンス・価格情報注文方法はこちら	306	324	英語

日本語のページは自動翻訳を利用し作成しています。

サマリー

世界の遠隔患者モニタリング市場は、2023年の140億米ドルから2028年には417億米ドルに達し、2023年から2028年の年平均成長率は20.1％になると予測されている。高齢者人口の増加、医療アクセスの拡大ニーズの高まり、医療資源の負担を軽減するRPMの能力、慢性疾患の有病率の上昇が、遠隔患者モニタリング（RPM）市場の成長を促す主な要因である。しかし、ソーシャルメディアの非公式な利用が予測期間中の市場成長を抑制する可能性がある。
"ソフトウェアとサービス分野が予測期間中、市場の最大シェアを占めると推定される"
製品に基づき、遠隔患者モニタリングはソフトウェア＆サービスとデバイスに区分される。予測期間中、ソフトウェア＆サービス分野が最大のシェアを占めると推定される。このセグメントの最大シェアは、主に利便性、遠隔患者モニタリングの高い有用性、IoT（モノのインターネット）で経験した技術革新によるものである。
"心臓モニタリング機器セグメントは2022年に市場で最大のシェアを占めると推定される"
タイプ別では、デバイス市場はさらに神経モニタリングデバイス、マルチパラメータモニタリングデバイス、心臓モニタリングデバイス、呼吸モニタリングデバイス、血糖モニタリングデバイス、胎児＆新生児モニタリングデバイス、その他のモニタリングデバイスにセグメント化される。2022年には、心臓モニタリング装置が遠隔患者モニタリング（RPM）市場で最大のシェアを占めた。高血圧と心血管疾患の有病率の増加が、この市場の成長を後押しすると推定されている。
2022年の遠隔患者モニタリング市場の用途別シェアは糖尿病分野が最大
アプリケーション別に見ると、世界の遠隔患者モニタリング市場は、腫瘍学、心血管疾患、糖尿病、睡眠障害、体重管理、フィットネスモニタリングに大別される。糖尿病セグメントは2022年の世界市場で最大のシェアを占めている。これは、糖尿病の有病率と慢性的な性質、継続的なモニタリング要件、技術の進歩に起因する。

2022年のエンドユーザー別遠隔患者モニタリング市場はプロバイダー分野が最大シェアを占める
世界の遠隔患者モニタリング（RPM）市場は、プロバイダー、支払者、患者、その他の4つの主要エンドユーザーセグメントに分けられる。プロバイダーセグメントが2022年の世界市場で最大のシェアを占めている。これは、RPMモニタリング機器が改良され、より多くの慢性疾患患者や高齢患者が遠隔モニタリングを利用し、プロバイダーがより多くのRPMサービスを提供しているためである。

「アジア太平洋地域は予測期間中に最も高いCAGRを記録すると予測される」。
アジア太平洋地域の市場は、予測期間中に最も高いCAGRを記録すると予測される。これは、インドや中国のような新興APAC諸国が、高齢者人口の増加、医療制度の改善、急速な経済発展、生活水準の向上により、遠隔患者モニタリング（RPM）企業にとって魅力的な市場となっているためである。

供給側の一次インタビューの内訳（企業タイプ別、呼称別、地域別
- 企業タイプ別ティア1（35％）、ティア2（45％）、ティア3（20）
- 役職別Cレベル(35%)、ディレクターレベル(25%)、その他(40%)
- 地域別北米 (25%)、欧州 (15%)、アジア太平洋 (45%)、中南米 (10%)、中東アフリカ (5%)

この市場に参入している主要企業には、オラクル（米国）、シーメンス・ヘルティニアスAG（ドイツ）、オムロンヘルスケア（日本）、ボストン・サイエンティフィック・コーポレーション（米国）、クリア・アーチ社（米国）、TytoCare Ltd. （米国）、Teledoc Health Ltd. （米国）、Teledoc Health Inc.(米国）、Teledoc Health Inc.（米国）、Vivify Health, Inc.（米国）、Koninklijke Philips N.V.（オランダ）、Brook Inc.(米国）、Blue Spark Technology社（米国）、Welch Allyn社（米国）、Health Beats社（シンガポール）、Medtronic社（アイルランド）、GE Healthcare社（米国）、Abbott Laboratories社（米国）、Alten Calsoft Labs社（フランス）、Bio-Beat社（イスラエル）、VitalConnect社（米国）、VivaLNK社（米国）、Bardy Diagnsotics社（米国）、Biotronik SE & Co.KG（ドイツ）、Alive Cor, Inc.（米国）、iRhythm Technologies（米国）。
調査範囲
- 遠隔患者モニタリング市場を製品、用途、エンドユーザー、地域別に調査しています。
- 市場成長に影響を与える要因（促進要因、阻害要因、機会、課題など）を分析しています。
- 利害関係者向けに市場の機会と課題を評価し、市場リーダー向けに競争環境の詳細を提供します。
- 微小市場の成長動向、将来性、遠隔患者モニタリング市場全体への貢献について調査しています。
- 主要5地域に関する市場セグメントの収益を予測しています。

レポート購入の主な利点

本レポートは、市場全体とサブセグメントの収益数の最も近い近似値に関する情報を提供し、この市場のリーダー/新規参入者に役立ちます。本レポートは、利害関係者が競争状況を理解し、より多くの洞察を得ることで、事業の位置づけを高め、適切な市場参入戦略を計画するのに役立ちます。また、関係者が医療用外骨格市場の脈拍を理解し、主要な市場促進要因、阻害要因、課題、機会に関する情報を提供するのに役立ちます。
本レポートは、以下のポイントに関する洞察を提供します：
- 主な促進要因の分析（老年人口および医療サービスが行き届いていない（特に農村部）人口の増加；慢性疾患の有病率の増加；パンデミックによる医師およびケア要員不足の現状に起因するテレヘルスおよび遠隔医療の利点；遠隔医療とRPMへの投資の増加、電気通信における技術進歩の高まり）、阻害要因（不十分なAI労働力、医療ソフトウェアに関するあいまいな規制ガイドライン）、機会（遠隔患者モニタリング市場におけるAIの役割と影響、感染症や伝染病対策におけるRPMの高い有用性）、課題（行動上の障壁、医療費負担、認識不足）。
- 市場への浸透：遠隔患者モニタリング市場のトップ企業が提供する製品ポートフォリオに関する包括的な情報。本レポートでは、この市場をタイプ別、用途別、エンドユーザー別に分析しています。
- サービスの強化/革新：遠隔患者モニタリング市場の今後の動向に関する詳細な洞察
- 市場開発：有利な新興市場のタイプ、アプリケーション、エンドユーザーに関する包括的な情報。
- 市場の多様化：遠隔患者モニタリング市場における新しいデバイスやソフトウェア、成長地域、最近の開発、投資に関する詳細情報
- 競合評価：遠隔患者モニタリング市場における主要企業の市場シェア、成長戦略、製品提供、企業評価象限、能力を詳細に評価します。

ページTOPに戻る

1 INTRODUCTION 39
1.1 STUDY OBJECTIVES 39
1.2 MARKET DEFINITION 39
1.2.1 INCLUSIONS AND EXCLUSIONS 40
1.3 MARKET SEGMENTATION 41
1.3.1 REGIONAL SEGMENTATION 41
1.3.2 YEARS CONSIDERED 42
1.3.3 CURRENCY CONSIDERED 42
1.4 STAKEHOLDERS 42
1.5 LIMITATIONS 43
1.5.1 SCOPE-RELATED LIMITATIONS 43
1.5.2 METHODOLOGY-RELATED LIMITATIONS 43
1.6 SUMMARY OF CHANGES 43
1.7 RECESSION IMPACT 44
2 RESEARCH METHODOLOGY 45
2.1 RESEARCH DATA 45
FIGURE 1 RESEARCH DESIGN 45
2.1.1 SECONDARY DATA 46
2.1.1.1 Key data from secondary sources 46
2.1.2 PRIMARY DATA 47
FIGURE 2 PRIMARY SOURCES 47
2.1.2.1 Key data from primary sources 48
FIGURE 3 INSIGHTS FROM INDUSTRY EXPERTS 48
2.1.2.2 Breakdown of primary sources 49
FIGURE 4 BREAKDOWN OF PRIMARY INTERVIEWS: BY COMPANY TYPE, DESIGNATION, AND REGION 49
2.2 MARKET SIZE ESTIMATION 49
FIGURE 5 RESEARCH METHODOLOGY: HYPOTHESIS BUILDING 50
FIGURE 6 REMOTE PATIENT MONITORING MARKET: ESTIMATION OF MARKET SIZE THROUGH ADOPTION-BASED APPROACH 51
FIGURE 7 CAGR PROJECTIONS FROM ANALYSIS OF DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES (2023–2028) 53
FIGURE 8 CAGR PROJECTIONS: SUPPLY-SIDE ANALYSIS 54
FIGURE 9 TOP-DOWN APPROACH 54
TABLE 1 IMPACT ANALYSIS 55
2.3 MARKET BREAKDOWN AND DATA TRIANGULATION 56
FIGURE 10 DATA TRIANGULATION METHODOLOGY 56
2.4 STUDY ASSUMPTIONS 57
2.5 RISK ASSESSMENT 57
TABLE 2 RISK ASSESSMENT ANALYSIS 57
2.6 RECESSION IMPACT ANALYSIS 58
3 EXECUTIVE SUMMARY 59
FIGURE 11 REMOTE PATIENT MONITORING MARKET, BY TYPE, 2023 VS. 2028 (USD MILLION) 59
FIGURE 12 REMOTE PATIENT MONITORING MARKET, BY APPLICATION, 2023 VS. 2028 (USD MILLION) 60
FIGURE 13 REMOTE PATIENT MONITORING MARKET, BY END USER, 2023 VS. 2028 (USD MILLION) 60
FIGURE 14 GEOGRAPHIC SNAPSHOT OF REMOTE PATIENT MONITORING MARKET 61
4 PREMIUM INSIGHTS 62
4.1 REMOTE PATIENT MONITORING MARKET OVERVIEW 62
FIGURE 15 RISING POPULATION AND GROWING FOCUS ON EXPANDING HEALTHCARE TO DRIVE MARKET DURING FORECAST PERIOD 62
4.2 ASIA PACIFIC: REMOTE PATIENT MONITORING MARKET, BY TYPE AND COUNTRY (2022) 63
FIGURE 16 SOFTWARE & SERVICES SEGMENT IN CHINA ACCOUNTED FOR LARGEST MARKET SHARE IN 2022 63
4.3 REMOTE PATIENT MONITORING MARKET: GEOGRAPHIC MIX 64
FIGURE 17 CHINA TO REGISTER HIGHEST GROWTH RATE DURING FORECAST PERIOD 64
4.4 REMOTE PATIENT MONITORING MARKET: DEVELOPED VS. EMERGING MARKETS 64
FIGURE 18 EMERGING MARKETS TO REGISTER HIGHER GROWTH RATE DURING FORECAST PERIOD 64
5 MARKET OVERVIEW 65
5.1 INTRODUCTION 65
FIGURE 19 REMOTE PATIENT MONITORING MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES 65
5.2 DRIVERS 66
5.2.1 GROWTH IN POPULATION AND SUBSEQUENT NEED TO EXPAND HEALTHCARE ACCESS 66
5.2.2 COST BENEFITS OF TELEHEALTH 66
TABLE 3 CHRONIC DISEASES AND COST BURDEN IN US: POTENTIAL SAVINGS 67
5.2.3 ABILITY TO REDUCE BURDEN ON MEDICAL RESOURCES 67
5.2.4 ADVANCEMENTS IN TELECOMMUNICATION 67
5.2.5 RISING INVESTMENTS IN TELEHEALTH SOLUTIONS 68
5.3 RESTRAINTS 68
5.3.1 VARIABLE REGULATORY STANDARDS ACROSS REGIONAL MARKETS 68
TABLE 4 US: STATE-WISE REGULATORY REQUIREMENTS FOR TELEHEALTH 69
5.3.2 HEALTHCARE FRAUD 70
5.3.3 INFORMAL USAGE OF SOCIAL MEDIA FOR HEALTHCARE PRACTICES 70
5.4 OPPORTUNITIES 70
5.4.1 IMPACT OF AI ON REMOTE PATIENT MONITORING 70
5.4.2 HIGH UTILIZATION IN INFECTIOUS DISEASE MONITORING 71
5.5 CHALLENGES 72
5.5.1 BEHAVIORAL BARRIERS AND HEALTHCARE AFFORDABILITY 72
5.5.2 DATA ACCESSIBILITY ISSUES 72
5.6 INDUSTRY TRENDS 72
5.6.1 GRADUAL SHIFT TO VALUE-BASED AND PATIENT-CENTRIC CARE 72
5.6.2 INNOVATIONS IN WEARABLE MEDICAL TECHNOLOGY 73
5.7 TARIFF AND REGULATORY ANALYSIS 74
5.7.1 TARIFF FOR REMOTE PATIENT MONITORING DEVICES 74
5.7.2 REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 74
TABLE 5 LIST OF REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 74
5.7.3 NORTH AMERICA 75
5.7.3.1 US 75
TABLE 6 US: CLASSIFICATION OF MEDICAL EQUIPMENT 75
TABLE 7 US: TIME, COST, AND COMPLEXITY OF REGISTRATION PROCESS 75
5.7.3.2 Canada 75
TABLE 8 CANADA: LEVEL OF RISK, TIME, COST, AND COMPLEXITY OF REGISTRATION PROCESS 75
5.7.3.3 Europe 76
TABLE 9 EUROPE: LEVEL OF RISK, TIME, COST, AND COMPLEXITY OF REGISTRATION PROCESS 76
5.7.3.4 Asia Pacific 76
5.7.3.4.1 Japan 76
TABLE 10 JAPAN: TIME, COST, AND COMPLEXITY OF REGISTRATION PROCESS 77
5.7.3.4.2 China 77
TABLE 11 CHINA: TIME, COST, AND COMPLEXITY OF REGISTRATION PROCESS 78
5.7.3.4.3 India 78
5.8 ECOSYSTEM ANALYSIS 78
FIGURE 20 REMOTE PATIENT MONITORING MARKET: ECOSYSTEM ANALYSIS 79
5.9 VALUE CHAIN ANALYSIS 79
FIGURE 21 REMOTE PATIENT MONITORING MARKET: VALUE CHAIN ANALYSIS 80
5.10 TECHNOLOGY ANALYSIS 80
5.10.1 REMOTE PATIENT MONITORING MARKET: DIGITAL TECHNOLOGY ENABLERS, BENEFITS, AND EXAMPLES 80
5.11 PATENT ANALYSIS 81
5.11.1 PATENT PUBLICATION TRENDS 81
FIGURE 22 PATENT PUBLICATION TRENDS: JANUARY 2011−SEPTEMBER 2023 82
5.11.2 JURISDICTION ANALYSIS: TOP APPLICANTS (COUNTRIES) FOR REMOTE PATIENT MONITORING PATENTS (2011−2023) 82
TABLE 12 JURISDICTION ANALYSIS: TOP APPLICANT COUNTRIES FOR REMOTE PATIENT MONITORING PATENTS 82
5.11.3 REMOTE PATIENT MONITORING MARKET: TOP APPLICANTS 83
FIGURE 23 TOP APPLICANTS FOR REMOTE PATIENT MONITORING PATENTS (2011–2023) 83
5.11.4 REMOTE PATIENT MONITORING MARKET: LIST OF PATENTS/PATENT APPLICATIONS 83
5.12 TRADE ANALYSIS 84
5.12.1 TRADE ANALYSIS FOR REMOTE PATIENT MONITORING DEVICES 85
FIGURE 24 IMPORT OF PRODUCTS UNDER HSN CODE: 90189099, BY COUNTRY, 2022 (USD THOUSAND) 85
FIGURE 25 EXPORTS OF PRODUCTS UNDER HSN CODE: 90189099, BY COUNTRY, 2022 (USD THOUSAND) 85
5.13 CASE STUDY ANALYSIS 86
TABLE 13 CASE STUDY 1: INTEGRATION OF GARMIN WEARABLE DEVICE DATA INTO MEDTRONIC CARE MANAGEMENT SERVICES (MCMS) RPM PLATFORM 86
TABLE 14 CASE STUDY 2: MOTION-SENSOR TECHNOLOGY FOR EARLY DETECTION OF CVD 86
5.14 PORTER’S FIVE FORCES ANALYSIS 87
TABLE 15 REMOTE PATIENT MONITORING MARKET: PORTER’S FIVE FORCES ANALYSIS 87
5.14.1 THREAT OF NEW ENTRANTS 87
5.14.2 THREAT OF SUBSTITUTES 88
5.14.3 BARGAINING POWER OF MANUFACTURERS 88
5.14.4 BARGAINING POWER OF BUYERS 88
5.14.5 INTENSITY OF COMPETITIVE RIVALRY 88
5.15 KEY CONFERENCES AND EVENTS 89
5.15.1 LIST OF KEY CONFERENCES AND EVENTS (2023−2024) 89
5.16 KEY STAKEHOLDERS AND BUYING CRITERIA 90
5.16.1 KEY STAKEHOLDERS IN BUYING PROCESS 90
TABLE 16 INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS FOR REMOTE PATIENT MONITORING 90
TABLE 17 INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS FOR REMOTE PATIENT MONITORING, BY TYPE 91
5.16.2 BUYING CRITERIA 91
FIGURE 26 KEY BUYING CRITERIA FOR REMOTE PATIENT MONITORING, BY TYPE 91
TABLE 18 KEY BUYING CRITERIA FOR REMOTE PATIENT MONITORING 91
5.17 PRICING ANALYSIS 92
TABLE 19 AVERAGE SELLING PRICE FOR REMOTE PATIENT MONITORING DEVICES, BY KEY PLAYERS (2022) 92
TABLE 20 AVERAGE SELLING PRICE FOR REMOTE PATIENT MONITORING DEVICES, BY KEY DEVICES (2022) 93
TABLE 21 INDICATIVE PRICING ANALYSIS OF REMOTE PATIENT MONITORING DEVICES, BY REGION, 2021 (USD) 93
5.18 REMOTE PATIENT MONITORING MARKET: UNMET NEEDS ANALYSIS 94
TABLE 22 UNMET NEEDS IN REMOTE PATIENT MONITORING MARKET 94
5.18.1 REMOTE PATIENT MONITORING MARKET: END-USER EXPECTATIONS 94
TABLE 23 END-USER EXPECTATIONS IN REMOTE PATIENT MONITORING MARKET 95
5.19 REIMBURSEMENT SCENARIO 96
TABLE 24 CPT CODES AND REIMBURSEMENT ANALYSIS OF US RPM MARKET 96
5.20 TRENDS/DISRUPTIONS IMPACTING CUSTOMERS’ BUSINESSES 97
5.20.1 REVENUE SHIFTS AND NEW REVENUE POCKETS FOR REMOTE PATIENT MONITORING MARKET 97
6 REMOTE PATIENT MONITORING MARKET, BY TYPE 98
6.1 INTRODUCTION 99
TABLE 25 REMOTE PATIENT MONITORING MARKET, BY TYPE, 2021–2028 (USD MILLION) 99
6.2 SOFTWARE & SERVICES 99
6.2.1 AVAILABILITY OF REIMBURSEMENTS FOR RPM SERVICES TO PROPEL MARKET 99
TABLE 26 REMOTE PATIENT MONITORING MARKET FOR SOFTWARE & SERVICES, BY REGION, 2021–2028 (USD MILLION) 100
TABLE 27 NORTH AMERICA: REMOTE PATIENT MONITORING MARKET FOR SOFTWARE & SERVICES, BY COUNTRY, 2021–2028 (USD MILLION) 101
TABLE 28 EUROPE: REMOTE PATIENT MONITORING MARKET FOR SOFTWARE & SERVICES, BY COUNTRY, 2021–2028 (USD MILLION) 101
TABLE 29 ASIA PACIFIC: REMOTE PATIENT MONITORING MARKET FOR SOFTWARE & SERVICES, BY COUNTRY, 2021–2028 (USD MILLION) 102
TABLE 30 LATIN AMERICA: REMOTE PATIENT MONITORING MARKET FOR SOFTWARE & SERVICES, BY COUNTRY, 2021–2028 (USD MILLION) 102
6.3 DEVICES 102
TABLE 31 REMOTE PATIENT MONITORING MARKET FOR DEVICES, BY TYPE, 2021–2028 (USD MILLION) 103
TABLE 32 REMOTE PATIENT MONITORING MARKET FOR DEVICES, BY REGION, 2021–2028 (USD MILLION) 104
TABLE 33 NORTH AMERICA: REMOTE PATIENT MONITORING MARKET FOR DEVICES, BY COUNTRY, 2021–2028 (USD MILLION) 104
TABLE 34 EUROPE: REMOTE PATIENT MONITORING MARKET FOR DEVICES, BY COUNTRY, 2021–2028 (USD MILLION) 105
TABLE 35 ASIA PACIFIC: REMOTE PATIENT MONITORING MARKET FOR DEVICES, BY COUNTRY, 2021–2028 (USD MILLION) 105
TABLE 36 LATIN AMERICA: REMOTE PATIENT MONITORING MARKET FOR DEVICES, BY COUNTRY, 2021–2028 (USD MILLION) 106
6.3.1 CARDIAC MONITORING DEVICES 106
TABLE 37 REMOTE PATIENT MONITORING MARKET FOR CARDIAC MONITORING DEVICES, BY REGION, 2021–2028 (USD MILLION) 107
TABLE 38 NORTH AMERICA: REMOTE PATIENT MONITORING MARKET FOR CARDIAC MONITORING DEVICES, BY COUNTRY, 2021–2028 (USD MILLION) 107
TABLE 39 EUROPE: REMOTE PATIENT MONITORING MARKET FOR CARDIAC MONITORING DEVICES, BY COUNTRY, 2021–2028 (USD MILLION) 108
TABLE 40 ASIA PACIFIC: REMOTE PATIENT MONITORING MARKET FOR CARDIAC MONITORING DEVICES, BY COUNTRY, 2021–2028 (USD MILLION) 108
TABLE 41 LATIN AMERICA: REMOTE PATIENT MONITORING MARKET FOR CARDIAC MONITORING DEVICES, BY COUNTRY, 2021–2028 (USD MILLION) 109
TABLE 42 REMOTE PATIENT MONITORING MARKET FOR CARDIAC MONITORING DEVICES, BY TYPE, 2021–2028 (USD MILLION) 109
6.3.1.1 BLOOD PRESSURE MONITORING DEVICES 109
6.3.1.1.1 Growing preference for wearable smartphone-connected devices to boost demand 109
TABLE 43 REMOTE PATIENT MONITORING MARKET FOR BLOOD PRESSURE MONITORING DEVICES, BY REGION, 2021–2028 (USD MILLION) 110
6.3.2 NEUROLOGICAL MONITORING DEVICES 110
6.3.2.1 Rising cases of epilepsy and Alzheimer’s to support market growth 110
TABLE 44 REMOTE PATIENT MONITORING MARKET FOR NEUROLOGICAL MONITORING DEVICES, BY REGION, 2021–2028 (USD MILLION) 111
TABLE 45 NORTH AMERICA: REMOTE PATIENT MONITORING MARKET FOR NEUROLOGICAL MONITORING DEVICES, BY COUNTRY, 2021–2028 (USD MILLION) 111
TABLE 46 EUROPE: REMOTE PATIENT MONITORING MARKET FOR NEUROLOGICAL MONITORING DEVICES, BY COUNTRY, 2021–2028 (USD MILLION) 112
TABLE 47 ASIA PACIFIC: REMOTE PATIENT MONITORING MARKET FOR NEUROLOGICAL MONITORING DEVICES, BY COUNTRY, 2021–2028 (USD MILLION) 112
TABLE 48 LATIN AMERICA: REMOTE PATIENT MONITORING MARKET FOR NEUROLOGICAL MONITORING DEVICES, BY COUNTRY, 2021–2028 (USD MILLION) 113
6.3.3 RESPIRATORY MONITORING DEVICES 113
6.3.3.1 Growing adoption of pulse oximeters to drive market 113
TABLE 49 REMOTE PATIENT MONITORING MARKET FOR RESPIRATORY MONITORING DEVICES, BY REGION, 2021–2028 (USD MILLION) 114
TABLE 50 NORTH AMERICA: REMOTE PATIENT MONITORING MARKET FOR RESPIRATORY MONITORING DEVICES, BY COUNTRY, 2021–2028 (USD MILLION) 114
TABLE 51 EUROPE: REMOTE PATIENT MONITORING MARKET FOR RESPIRATORY MONITORING DEVICES, BY COUNTRY, 2021–2028 (USD MILLION) 115
TABLE 52 ASIA PACIFIC: REMOTE PATIENT MONITORING MARKET FOR RESPIRATORY MONITORING DEVICES, BY COUNTRY, 2021–2028 (USD MILLION) 115
TABLE 53 LATIN AMERICA: REMOTE PATIENT MONITORING MARKET FOR RESPIRATORY MONITORING DEVICES, BY COUNTRY, 2021–2028 (USD MILLION) 116
6.3.4 MULTIPARAMETER MONITORING DEVICES 116
6.3.4.1 Ability to measure multi-physiological and biochemical ranges to boost demand 116
TABLE 54 REMOTE PATIENT MONITORING MARKET FOR MULTIPARAMETER MONITORING DEVICES, BY REGION, 2021–2028 (USD MILLION) 117
TABLE 55 NORTH AMERICA: REMOTE PATIENT MONITORING MARKET FOR MULTIPARAMETER MONITORING DEVICES, BY COUNTRY, 2021–2028 (USD MILLION) 117
TABLE 56 EUROPE: REMOTE PATIENT MONITORING MARKET FOR MULTIPARAMETER MONITORING DEVICES, BY COUNTRY, 2021–2028 (USD MILLION) 118
TABLE 57 ASIA PACIFIC: REMOTE PATIENT MONITORING MARKET FOR MULTIPARAMETER MONITORING DEVICES, BY COUNTRY, 2021–2028 (USD MILLION) 118
TABLE 58 LATIN AMERICA: REMOTE PATIENT MONITORING MARKET FOR MULTIPARAMETER MONITORING DEVICES, BY COUNTRY, 2021–2028 (USD MILLION) 119
6.3.5 BLOOD GLUCOSE MONITORING DEVICES 119
6.3.5.1 High incidence of diabetes to drive market 119
TABLE 59 REMOTE PATIENT MONITORING MARKET FOR BLOOD GLUCOSE MONITORING DEVICES, BY REGION, 2021–2028 (USD MILLION) 120
TABLE 60 NORTH AMERICA: REMOTE PATIENT MONITORING MARKET FOR BLOOD GLUCOSE MONITORING DEVICES, BY COUNTRY, 2021–2028 (USD MILLION) 120
TABLE 61 EUROPE: REMOTE PATIENT MONITORING MARKET FOR BLOOD GLUCOSE MONITORING DEVICES, BY COUNTRY, 2021–2028 (USD MILLION) 121
TABLE 62 ASIA PACIFIC: REMOTE PATIENT MONITORING MARKET FOR BLOOD GLUCOSE MONITORING DEVICES, BY COUNTRY, 2021–2028 (USD MILLION) 121
TABLE 63 LATIN AMERICA: REMOTE PATIENT MONITORING MARKET FOR BLOOD GLUCOSE MONITORING DEVICES, BY COUNTRY, 2021–2028 (USD MILLION) 122
6.3.6 FETAL & NEONATAL MONITORING DEVICES 122
6.3.6.1 Rising number of preterm births to propel market for RPM devices 122
TABLE 64 REMOTE PATIENT MONITORING MARKET FOR FETAL & NEONATAL MONITORING DEVICES, BY REGION, 2021–2028 (USD MILLION) 123
TABLE 65 NORTH AMERICA: REMOTE PATIENT MONITORING MARKET FOR FETAL & NEONATAL MONITORING DEVICES, BY COUNTRY, 2021–2028 (USD MILLION) 123
TABLE 66 EUROPE: REMOTE PATIENT MONITORING MARKET FOR FETAL & NEONATAL MONITORING DEVICES, BY COUNTRY, 2021–2028 (USD MILLION) 124
TABLE 67 ASIA PACIFIC: REMOTE PATIENT MONITORING MARKET FOR FETAL & NEONATAL MONITORING DEVICES, BY COUNTRY, 2021–2028 (USD MILLION) 124
TABLE 68 LATIN AMERICA: REMOTE PATIENT MONITORING MARKET FOR FETAL & NEONATAL MONITORING DEVICES, BY COUNTRY, 2021–2028 (USD MILLION) 125
6.3.7 WEIGHT MONITORING DEVICES 125
6.3.7.1 Rising obesity levels to fuel uptake 125
TABLE 69 REMOTE PATIENT MONITORING MARKET FOR WEIGHT MONITORING DEVICES, BY REGION, 2021–2028 (USD MILLION) 126
TABLE 70 NORTH AMERICA: REMOTE PATIENT MONITORING MARKET FOR WEIGHT MONITORING DEVICES, BY COUNTRY, 2021–2028 (USD MILLION) 126
TABLE 71 EUROPE: REMOTE PATIENT MONITORING MARKET FOR WEIGHT MONITORING DEVICES, BY COUNTRY, 2021–2028 (USD MILLION) 127
TABLE 72 ASIA PACIFIC: REMOTE PATIENT MONITORING MARKET FOR WEIGHT MONITORING DEVICES, BY COUNTRY, 2021–2028 (USD MILLION) 127
TABLE 73 LATIN AMERICA: REMOTE PATIENT MONITORING MARKET FOR WEIGHT MONITORING DEVICES, BY COUNTRY, 2021–2028 (USD MILLION) 128
6.3.8 OTHER MONITORING DEVICES 128
TABLE 74 REMOTE PATIENT MONITORING MARKET FOR OTHER MONITORING DEVICES, BY REGION, 2021–2028 (USD MILLION) 129
TABLE 75 NORTH AMERICA: REMOTE PATIENT MONITORING MARKET FOR OTHER MONITORING DEVICES, BY COUNTRY, 2021–2028 (USD MILLION) 129
TABLE 76 EUROPE: REMOTE PATIENT MONITORING MARKET FOR OTHER MONITORING DEVICES, BY COUNTRY, 2021–2028 (USD MILLION) 130
TABLE 77 ASIA PACIFIC: REMOTE PATIENT MONITORING MARKET FOR OTHER MONITORING DEVICES, BY COUNTRY, 2021–2028 (USD MILLION) 130
TABLE 78 LATIN AMERICA: REMOTE PATIENT MONITORING MARKET FOR OTHER MONITORING DEVICES, BY COUNTRY, 2021–2028 (USD MILLION) 131
7 REMOTE PATIENT MONITORING MARKET, BY APPLICATION 132
7.1 INTRODUCTION 133
TABLE 79 REMOTE PATIENT MONITORING MARKET, BY APPLICATION, 2021–2028 (USD MILLION) 133
7.2 ONCOLOGY 133
7.2.1 RISING INCIDENCE OF CANCER TO PROPEL MARKET 133
TABLE 80 REMOTE PATIENT MONITORING MARKET FOR ONCOLOGY, BY REGION, 2021–2028 (USD MILLION) 134
TABLE 81 NORTH AMERICA: REMOTE PATIENT MONITORING MARKET FOR ONCOLOGY, BY COUNTRY, 2021–2028 (USD MILLION) 134
TABLE 82 EUROPE: REMOTE PATIENT MONITORING MARKET FOR ONCOLOGY, BY COUNTRY, 2021–2028 (USD MILLION) 135
TABLE 83 ASIA PACIFIC: REMOTE PATIENT MONITORING MARKET FOR ONCOLOGY, BY COUNTRY, 2021–2028 (USD MILLION) 135
TABLE 84 LATIN AMERICA: REMOTE PATIENT MONITORING MARKET FOR ONCOLOGY, BY COUNTRY, 2021–2028 (USD MILLION) 136
7.3 CARDIOVASCULAR DISEASES 136
7.3.1 HIGH INCIDENCE OF CVD TO SUPPORT MARKET GROWTH 136
TABLE 85 REMOTE PATIENT MONITORING MARKET FOR CARDIOVASCULAR DISEASES, BY REGION, 2021–2028 (USD MILLION) 136
TABLE 86 NORTH AMERICA: REMOTE PATIENT MONITORING MARKET FOR CARDIOVASCULAR DISEASES, BY COUNTRY, 2021–2028 (USD MILLION) 137
TABLE 87 EUROPE: REMOTE PATIENT MONITORING MARKET FOR CARDIOVASCULAR DISEASES, BY COUNTRY, 2021–2028 (USD MILLION) 137
TABLE 88 ASIA PACIFIC: REMOTE PATIENT MONITORING MARKET FOR CARDIOVASCULAR DISEASES, BY COUNTRY, 2021–2028 (USD MILLION) 137
TABLE 89 LATIN AMERICA: REMOTE PATIENT MONITORING MARKET FOR CARDIOVASCULAR DISEASES, BY COUNTRY, 2021–2028 (USD MILLION) 138
7.4 DIABETES 138
7.4.1 TECHNOLOGICAL ADVANCEMENTS IN WEARABLE MONITORS TO BOOST DEMAND 138
TABLE 90 REMOTE PATIENT MONITORING MARKET FOR DIABETES, BY REGION, 2021–2028 (USD MILLION) 139
TABLE 91 NORTH AMERICA: REMOTE PATIENT MONITORING MARKET FOR DIABETES, BY COUNTRY, 2021–2028 (USD MILLION) 139
TABLE 92 EUROPE: REMOTE PATIENT MONITORING MARKET FOR DIABETES, BY COUNTRY, 2021–2028 (USD MILLION) 140
TABLE 93 ASIA PACIFIC: REMOTE PATIENT MONITORING MARKET FOR DIABETES, BY COUNTRY, 2021–2028 (USD MILLION) 140
TABLE 94 LATIN AMERICA: REMOTE PATIENT MONITORING MARKET FOR DIABETES, BY COUNTRY, 2021–2028 (USD MILLION) 141
7.5 SLEEP DISORDERS 141
7.5.1 WIDE UTILIZATION IN SLEEP APNEA MANAGEMENT TO PROPEL MARKET 141
TABLE 95 REMOTE PATIENT MONITORING MARKET FOR SLEEP DISORDERS, BY REGION, 2021–2028 (USD MILLION) 142
TABLE 96 NORTH AMERICA: REMOTE PATIENT MONITORING MARKET FOR SLEEP DISORDERS, BY COUNTRY, 2021–2028 (USD MILLION) 142
TABLE 97 EUROPE REMOTE PATIENT MONITORING MARKET FOR SLEEP DISORDERS, BY COUNTRY, 2021–2028 (USD MILLION) 143
TABLE 98 ASIA PACIFIC: REMOTE PATIENT MONITORING MARKET FOR SLEEP DISORDERS, BY COUNTRY, 2021–2028 (USD MILLION) 143
TABLE 99 LATIN AMERICA: REMOTE PATIENT MONITORING MARKET FOR SLEEP DISORDERS, BY COUNTRY, 2021–2028 (USD MILLION) 144
7.6 WEIGHT MANAGEMENT AND FITNESS MONITORING 144
7.6.1 CHRONIC DISEASE MANAGEMENT TO SUPPORT MARKET GROWTH 144
TABLE 100 REMOTE PATIENT MONITORING MARKET FOR WEIGHT MANAGEMENT AND FITNESS MONITORING, BY REGION, 2021–2028 (USD MILLION) 145
TABLE 101 NORTH AMERICA: REMOTE PATIENT MONITORING MARKET FOR WEIGHT MANAGEMENT AND FITNESS MONITORING, BY COUNTRY, 2021–2028 (USD MILLION) 145
TABLE 102 EUROPE: REMOTE PATIENT MONITORING MARKET FOR WEIGHT MANAGEMENT AND FITNESS MONITORING, BY COUNTRY, 2021–2028 (USD MILLION) 146
TABLE 103 ASIA PACIFIC: REMOTE PATIENT MONITORING MARKET FOR WEIGHT MANAGEMENT & FITNESS MONITORING, BY COUNTRY, 2021–2028 (USD MILLION) 146
TABLE 104 LATIN AMERICA: REMOTE PATIENT MONITORING MARKET FOR WEIGHT MANAGEMENT AND FITNESS MONITORING, BY COUNTRY, 2021–2028 (USD MILLION) 147
7.7 OTHER APPLICATIONS 147
TABLE 105 REMOTE PATIENT MONITORING MARKET FOR OTHER APPLICATIONS, BY REGION, 2021–2028 (USD MILLION) 148
TABLE 106 NORTH AMERICA: REMOTE PATIENT MONITORING MARKET FOR OTHER APPLICATIONS, BY COUNTRY, 2021–2028 (USD MILLION) 148
TABLE 107 EUROPE: REMOTE PATIENT MONITORING MARKET FOR OTHER APPLICATIONS, BY COUNTRY, 2021–2028 (USD MILLION) 149
TABLE 108 ASIA PACIFIC: REMOTE PATIENT MONITORING MARKET FOR OTHER APPLICATIONS, BY COUNTRY, 2021–2028 (USD MILLION) 149
TABLE 109 LATIN AMERICA: REMOTE PATIENT MONITORING MARKET FOR OTHER APPLICATIONS, BY COUNTRY, 2021–2028 (USD MILLION) 150
8 REMOTE PATIENT MONITORING MARKET, BY END USER 151
8.1 INTRODUCTION 152
TABLE 110 REMOTE PATIENT MONITORING MARKET, BY END USER, 2021–2028 (USD MILLION) 152
8.2 PROVIDERS 152
TABLE 111 REMOTE PATIENT MONITORING MARKET FOR PROVIDERS, BY TYPE, 2021–2028 (USD MILLION) 153
TABLE 112 REMOTE PATIENT MONITORING MARKET FOR PROVIDERS, BY REGION, 2021–2028 (USD MILLION) 154
TABLE 113 NORTH AMERICA: REMOTE PATIENT MONITORING MARKET FOR PROVIDERS, BY COUNTRY, 2021–2028 (USD MILLION) 154
TABLE 114 EUROPE: REMOTE PATIENT MONITORING MARKET FOR PROVIDERS, BY COUNTRY, 2021–2028 (USD MILLION) 155
TABLE 115 ASIA PACIFIC: REMOTE PATIENT MONITORING MARKET FOR PROVIDERS, BY COUNTRY, 2021–2028 (USD MILLION) 155
TABLE 116 LATIN AMERICA: REMOTE PATIENT MONITORING MARKET FOR PROVIDERS, BY COUNTRY, 2021–2028 (USD MILLION) 156
8.2.1 HOSPITALS AND CLINICS 156
8.2.1.1 High incidence of infectious diseases to boost demand 156
TABLE 117 REMOTE PATIENT MONITORING MARKET FOR HOSPITALS AND CLINICS, BY REGION, 2021–2028 (USD MILLION) 157
TABLE 118 NORTH AMERICA: REMOTE PATIENT MONITORING MARKET FOR HOSPITALS AND CLINICS, BY COUNTRY, 2021–2028 (USD MILLION) 157
TABLE 119 EUROPE: REMOTE PATIENT MONITORING MARKET FOR HOSPITALS AND CLINICS, BY COUNTRY, 2021–2028 (USD MILLION) 158
TABLE 120 ASIA PACIFIC: REMOTE PATIENT MONITORING MARKET FOR HOSPITALS AND CLINICS, BY COUNTRY, 2021–2028 (USD MILLION) 158
TABLE 121 LATIN AMERICA: REMOTE PATIENT MONITORING MARKET FOR HOSPITALS AND CLINICS, BY COUNTRY, 2021–2028 (USD MILLION) 159
8.2.2 HOME CARE SETTINGS AND LONG-TERM CARE CENTERS 159
8.2.2.1 Advancements in wearable health technology to support market growth 159
TABLE 122 REMOTE PATIENT MONITORING MARKET FOR HOME CARE SETTINGS AND LONG-TERM CARE CENTERS, BY REGION, 2021–2028 (USD MILLION) 160
TABLE 123 NORTH AMERICA: REMOTE PATIENT MONITORING MARKET FOR HOME CARE SETTINGS AND LONG-TERM CARE CENTERS, BY COUNTRY, 2021–2028 (USD MILLION) 160
TABLE 124 EUROPE: REMOTE PATIENT MONITORING MARKET FOR HOME CARE SETTINGS AND LONG-TERM CARE CENTERS, BY COUNTRY, 2021–2028 (USD MILLION) 161
TABLE 125 ASIA PACIFIC: REMOTE PATIENT MONITORING MARKET FOR HOME CARE SETTINGS AND LONG-TERM CARE CENTERS, BY COUNTRY, 2021–2028 (USD MILLION) 161
TABLE 126 LATIN AMERICA: REMOTE PATIENT MONITORING MARKET FOR HOME CARE SETTINGS AND LONG-TERM CARE CENTERS, BY COUNTRY, 2021–2028 (USD MILLION) 162
8.2.3 AMBULATORY CARE CENTERS 162
8.2.3.1 Gradual shift to outpatient settings to propel market 162
TABLE 127 REMOTE PATIENT MONITORING MARKET FOR AMBULATORY CARE CENTERS, BY REGION, 2021–2028 (USD MILLION) 163
TABLE 128 NORTH AMERICA: REMOTE PATIENT MONITORING MARKET FOR AMBULATORY CARE CENTERS, BY COUNTRY, 2021–2028 (USD MILLION) 163
TABLE 129 EUROPE: REMOTE PATIENT MONITORING MARKET FOR AMBULATORY CARE CENTERS, BY COUNTRY, 2021–2028 (USD MILLION) 164
TABLE 130 ASIA PACIFIC: REMOTE PATIENT MONITORING MARKET FOR AMBULATORY CARE CENTERS, BY COUNTRY, 2021–2028 (USD MILLION) 164
TABLE 131 LATIN AMERICA: REMOTE PATIENT MONITORING MARKET FOR AMBULATORY CARE CENTERS, BY COUNTRY, 2021–2028 (USD MILLION) 165
8.2.4 OTHER PROVIDERS 165
TABLE 132 REMOTE PATIENT MONITORING MARKET FOR OTHER PROVIDERS, BY REGION, 2021–2028 (USD MILLION) 165
TABLE 133 NORTH AMERICA: REMOTE PATIENT MONITORING MARKET FOR OTHER PROVIDERS, BY COUNTRY, 2021–2028 (USD MILLION) 166
TABLE 134 EUROPE: REMOTE PATIENT MONITORING MARKET FOR OTHER PROVIDERS, BY COUNTRY, 2021–2028 (USD MILLION) 166
TABLE 135 ASIA PACIFIC: REMOTE PATIENT MONITORING MARKET FOR OTHER PROVIDERS, BY COUNTRY, 2021–2028 (USD MILLION) 167
TABLE 136 LATIN AMERICA: REMOTE PATIENT MONITORING MARKET FOR OTHER PROVIDERS, BY COUNTRY, 2021–2028 (USD MILLION) 167
8.3 PAYERS 167
8.3.1 INCREASING REIMBURSEMENTS FOR RPM SOLUTIONS TO PROPEL MARKET 167
TABLE 137 REMOTE PATIENT MONITORING MARKET FOR PAYERS, BY REGION, 2021–2028 (USD MILLION) 168
TABLE 138 NORTH AMERICA: REMOTE PATIENT MONITORING MARKET FOR PAYERS, BY COUNTRY, 2021–2028 (USD MILLION) 168
TABLE 139 EUROPE: REMOTE PATIENT MONITORING MARKET FOR PAYERS, BY COUNTRY, 2021–2028 (USD MILLION) 169
TABLE 140 ASIA PACIFIC: REMOTE PATIENT MONITORING MARKET FOR PAYERS, BY COUNTRY, 2021–2028 (USD MILLION) 169
TABLE 141 LATIN AMERICA: REMOTE PATIENT MONITORING MARKET FOR PAYERS, BY COUNTRY, 2021–2028 (USD MILLION) 170
8.4 PATIENTS 170
8.4.1 COST-BENEFITS AND CONVENIENCE OFFERED BY RPM TO SUPPORT MARKET 170
TABLE 142 REMOTE PATIENT MONITORING MARKET FOR PATIENTS, BY REGION, 2021–2028 (USD MILLION) 171
TABLE 143 NORTH AMERICA: REMOTE PATIENT MONITORING MARKET FOR PATIENTS, BY COUNTRY, 2021–2028 (USD MILLION) 171
TABLE 144 EUROPE: REMOTE PATIENT MONITORING MARKET FOR PATIENTS, BY COUNTRY, 2021–2028 (USD MILLION) 172
TABLE 145 ASIA PACIFIC: REMOTE PATIENT MONITORING MARKET FOR PATIENTS, BY COUNTRY, 2021–2028 (USD MILLION) 172
TABLE 146 LATIN AMERICA: REMOTE PATIENT MONITORING MARKET FOR PATIENTS, BY COUNTRY, 2021–2028 (USD MILLION) 173
8.5 OTHER END USERS 173
TABLE 147 REMOTE PATIENT MONITORING MARKET FOR OTHER END USERS, BY REGION, 2021–2028 (USD MILLION) 174
TABLE 148 NORTH AMERICA: REMOTE PATIENT MONITORING MARKET FOR OTHER END USERS, BY COUNTRY, 2021–2028 (USD MILLION) 174
TABLE 149 EUROPE: REMOTE PATIENT MONITORING MARKET FOR OTHER END USERS, BY COUNTRY, 2021–2028 (USD MILLION) 175
TABLE 150 ASIA PACIFIC: REMOTE PATIENT MONITORING MARKET FOR OTHER END USERS, BY COUNTRY, 2021–2028 (USD MILLION) 175
TABLE 151 LATIN AMERICA: REMOTE PATIENT MONITORING MARKET FOR OTHER END USERS, BY COUNTRY, 2021–2028 (USD MILLION) 176
9 REMOTE PATIENT MONITORING MARKET, BY REGION 177
9.1 INTRODUCTION 178
TABLE 152 REMOTE PATIENT MONITORING MARKET, BY REGION, 2021–2028 (USD MILLION) 178
9.2 NORTH AMERICA 178
FIGURE 27 NORTH AMERICA: REMOTE PATIENT MONITORING MARKET SNAPSHOT 179
9.2.1 NORTH AMERICA: RECESSION IMPACT 179
TABLE 153 NORTH AMERICA: REMOTE PATIENT MONITORING MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 180
TABLE 154 NORTH AMERICA: REMOTE PATIENT MONITORING MARKET, BY TYPE, 2021–2028 (USD MILLION) 180
TABLE 155 NORTH AMERICA: REMOTE PATIENT MONITORING DEVICES MARKET, BY TYPE, 2021–2028 (USD MILLION) 181
TABLE 156 NORTH AMERICA: REMOTE PATIENT MONITORING DEVICES MARKET, BY APPLICATION, 2021–2028 (USD MILLION) 182
TABLE 157 NORTH AMERICA: REMOTE PATIENT MONITORING MARKET, BY END USER, 2021–2028 (USD MILLION) 182
TABLE 158 NORTH AMERICA: REMOTE PATIENT MONITORING FOR PROVIDERS MARKET, BY END USER, 2021–2028 (USD MILLION) 183
9.2.2 US 183
9.2.2.1 High healthcare expenditure to boost demand for RPM services 183
TABLE 159 US: REMOTE PATIENT MONITORING MARKET, BY TYPE, 2021–2028 (USD MILLION) 184
TABLE 160 US: REMOTE PATIENT MONITORING DEVICES MARKET, BY TYPE, 2021–2028 (USD MILLION) 185
TABLE 161 US: REMOTE PATIENT MONITORING DEVICES MARKET, BY APPLICATION, 2021–2028 (USD MILLION) 185
TABLE 162 US: REMOTE PATIENT MONITORING MARKET, BY END USER, 2021–2028 (USD MILLION) 186
TABLE 163 US: REMOTE PATIENT MONITORING FOR PROVIDERS MARKET, BY END USER, 2021–2028 (USD MILLION) 186
9.2.3 CANADA 187
9.2.3.1 Rising incidence of CVD to support market growth 187
TABLE 164 CANADA: REMOTE PATIENT MONITORING MARKET, BY TYPE, 2021–2028 (USD MILLION) 187
TABLE 165 CANADA: REMOTE PATIENT MONITORING DEVICES MARKET, BY TYPE, 2021–2028 (USD MILLION) 188
TABLE 166 CANADA: REMOTE PATIENT MONITORING DEVICES MARKET, BY APPLICATION, 2021–2028 (USD MILLION) 188
TABLE 167 CANADA: REMOTE PATIENT MONITORING MARKET, BY END USER, 2021–2028 (USD MILLION) 189
TABLE 168 CANADA: REMOTE PATIENT MONITORING FOR PROVIDERS MARKET, BY END USER, 2021–2028 (USD MILLION) 189
9.3 EUROPE 190
9.3.1 EUROPE: RECESSION IMPACT 190
TABLE 169 EUROPE: REMOTE PATIENT MONITORING MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 191
TABLE 170 EUROPE: REMOTE PATIENT MONITORING MARKET, BY TYPE, 2021–2028 (USD MILLION) 191
TABLE 171 EUROPE: REMOTE PATIENT MONITORING DEVICES MARKET, BY TYPE, 2021–2028 (USD MILLION) 192
TABLE 172 EUROPE: REMOTE PATIENT MONITORING DEVICES MARKET, BY APPLICATION, 2021–2028 (USD MILLION) 192
TABLE 173 EUROPE: REMOTE PATIENT MONITORING MARKET, BY END USER, 2021–2028 (USD MILLION) 193
TABLE 174 EUROPE: REMOTE PATIENT MONITORING FOR PROVIDERS MARKET, BY END USER, 2021–2028 (USD MILLION) 193
9.3.2 GERMANY 194
9.3.2.1 Rapid digitization of healthcare systems to drive market growth 194
TABLE 175 GERMANY: REMOTE PATIENT MONITORING MARKET, BY TYPE, 2021–2028 (USD MILLION) 195
TABLE 176 GERMANY: REMOTE PATIENT MONITORING DEVICES MARKET, BY TYPE, 2021–2028 (USD MILLION) 195
TABLE 177 GERMANY: REMOTE PATIENT MONITORING DEVICES MARKET, BY APPLICATION, 2021–2028 (USD MILLION) 196
TABLE 178 GERMANY: REMOTE PATIENT MONITORING MARKET, BY END USER, 2021–2028 (USD MILLION) 196
TABLE 179 GERMANY: REMOTE PATIENT MONITORING FOR PROVIDERS MARKET, BY END USER, 2021–2028 (USD MILLION) 197
9.3.3 UK 197
9.3.3.1 Shortage of physicians to boost demand for telehealth solutions 197
TABLE 180 UK: REMOTE PATIENT MONITORING MARKET, BY TYPE, 2021–2028 (USD MILLION) 198
TABLE 181 UK: REMOTE PATIENT MONITORING DEVICES MARKET, BY TYPE, 2021–2028 (USD MILLION) 198
TABLE 182 UK: REMOTE PATIENT MONITORING DEVICES MARKET, BY APPLICATION, 2021–2028 (USD MILLION) 199
TABLE 183 UK: REMOTE PATIENT MONITORING MARKET, BY END USER, 2021–2028 (USD MILLION) 199
TABLE 184 UK: REMOTE PATIENT MONITORING MARKET FOR PROVIDERS, BY END USER, 2021–2028 (USD MILLION) 200
9.3.4 FRANCE 200
9.3.4.1 Favorable government initiatives for telehealth to support market growth 200
TABLE 185 FRANCE: REMOTE PATIENT MONITORING MARKET, BY TYPE, 2021–2028 (USD MILLION) 201
TABLE 186 FRANCE: REMOTE PATIENT MONITORING DEVICES MARKET, BY TYPE, 2021–2028 (USD MILLION) 201
TABLE 187 FRANCE: REMOTE PATIENT MONITORING DEVICES MARKET, BY APPLICATION, 2021–2028 (USD MILLION) 202
TABLE 188 FRANCE: REMOTE PATIENT MONITORING MARKET, BY END USER, 2021–2028 (USD MILLION) 202
TABLE 189 FRANCE: REMOTE PATIENT MONITORING FOR PROVIDERS MARKET, BY END USER, 2021–2028 (USD MILLION) 203
9.3.5 ITALY 203
9.3.5.1 Growing focus on improvements in patient care to drive market 203
TABLE 190 ITALY: REMOTE PATIENT MONITORING MARKET, BY TYPE, 2021–2028 (USD MILLION) 204
TABLE 191 ITALY: REMOTE PATIENT MONITORING DEVICES MARKET, BY TYPE, 2021–2028 (USD MILLION) 204
TABLE 192 ITALY: REMOTE PATIENT MONITORING DEVICES MARKET, BY APPLICATION, 2021–2028 (USD MILLION) 205
TABLE 193 ITALY: REMOTE PATIENT MONITORING MARKET, BY END USER, 2021–2028 (USD MILLION) 205
TABLE 194 ITALY: REMOTE PATIENT MONITORING FOR PROVIDERS MARKET, BY END USER, 2021–2028 (USD MILLION) 206
9.3.6 SPAIN 206
9.3.6.1 Rising incidence of chronic diseases to support market growth 206
TABLE 195 SPAIN: REMOTE PATIENT MONITORING MARKET, BY TYPE, 2021–2028 (USD MILLION) 207
TABLE 196 SPAIN: REMOTE PATIENT MONITORING DEVICES MARKET, BY TYPE, 2021–2028 (USD MILLION) 207
TABLE 197 SPAIN: REMOTE PATIENT MONITORING DEVICES MARKET, BY APPLICATION, 2021–2028 (USD MILLION) 208
TABLE 198 SPAIN: REMOTE PATIENT MONITORING MARKET, BY END USER, 2021–2028 (USD MILLION) 208
TABLE 199 SPAIN: REMOTE PATIENT MONITORING FOR PROVIDERS MARKET, BY END USER, 2021–2028 (USD MILLION) 209
9.3.7 REST OF EUROPE 209
TABLE 200 REST OF EUROPE: REMOTE PATIENT MONITORING MARKET, BY TYPE, 2021–2028 (USD MILLION) 210
TABLE 201 REST OF EUROPE: REMOTE PATIENT MONITORING DEVICES MARKET, BY TYPE, 2021–2028 (USD MILLION) 210
TABLE 202 REST OF EUROPE: REMOTE PATIENT MONITORING DEVICES MARKET, BY APPLICATION, 2021–2028 (USD MILLION) 211
TABLE 203 REST OF EUROPE: REMOTE PATIENT MONITORING MARKET, BY END USER, 2021–2028 (USD MILLION) 211
TABLE 204 REST OF EUROPE: REMOTE PATIENT MONITORING FOR PROVIDERS MARKET, BY END USER, 2021–2028 (USD MILLION) 212

ページTOPに戻る

Table of Contents

Summary

The global remote patient monitoring market is projected to reach USD 41.7 billion by 2028 from USD 14.0 billion in 2023, at a CAGR of 20.1% between 2023 and 2028. The increasing elderly population, the growing need to expand healthcare access, the ability of RPM to reduce the burden on medical resources and the rising prevalence of chronic diseases are the main factors driving the growth of the remote patient monitoring (RPM) market. However, informal use of social media could restrain market growth during the forecast period.
“Software and services segment is estimated to account for the largest share of the market during the forecast period”
Based on product, remote patient monitoring is segmented into software & services and devices. The software & services segment is estimated to account for the largest share during the forecast period. The largest share of this segment is mainly due to the convenience, the high utility of remote patient monitoring, and innovations experienced in the IoT (Internet of Things).
“Cardiac monitoring devices segment is estimated to account for the largest share of the market in 2022”
On the basis of type, the devices market is further segmented into neurological monitoring devices, multiparameter monitoring devices , cardiac monitoring devices, respiratory monitoring devices, blood glucose monitoring devices, fetal & neonatal monitoring devices, and other monitoring devices. In 2022, cardiac monitoring devices held the largest share of the remote patient monitoring (RPM) market. The growing prevalence of individuals with hypertension and cardiovascular diseases is estimated to boost the growth of this market.
Diabetes segment accounted for the largest share of the remote patient monitoring market, by application, in 2022
Based on application, the global remote patient monitoring market is broadly segmented into oncology, cardiovascular diseases, diabetes, sleep disorders, weight management and fitness monitoring. The diabetes segment accounted for the largest share of the global market in 2022. This can be attributed to the prevalence and chronic nature of diabetes, continuous monitoring requirements, and technological advancements.

Providers segment accounted for the largest share of the remote patient monitoring market, by end user, in 2022
The global remote patient monitoring (RPM) market is divided into four main end-user segments: providers, payers, patients, and others. The providers segment held the largest share of the global market in 2022. This is because RPM monitoring devices are improving, more chronically ill and elderly patients are using remote monitoring, and providers are offering more RPM services.

“Asia Pacific is projected to register the highest CAGR during the forecast period”.
The market in the Asia Pacific region, is projected to register the highest CAGR during the forecast period. This can be attributed to the emerging APAC countries like India and China are attractive markets for remote patient monitoring (RPM) companies, thanks to their growing elderly population, improving healthcare systems, rapid economic development, and rising living standards.

Breakdown of supply-side primary interviews, by company type, designation, and region:
• By Company Type: Tier 1 (35%), Tier 2 (45%), and Tier 3 (20%)
• By Designation: C-level (35%), Director-level (25%), and Others (40%)
• By Region: North America (25%), Europe (15%), Asia Pacific (45%), Latin America (10%), and Middle East Africa (5%)

The key players operating in this market include Oracle (US), Siemens Healthineers AG (Germany), Omron Healthcare (Japan), Boston Scientific Corporation (US), Clear Arch, Inc (US), TytoCare Ltd. (US), Teledoc Health Inc. (US), Vivify Health, Inc. (US), Koninklijke Philips N.V. (Netherlands), Brook Inc. (US), Blue Spark Technology (US), Welch Allyn (US), Health Beats (Singapore),Medtronic (Ireland), GE Healthcare (US), Abbott Laboratories (US), Alten Calsoft Labs (France), Bio-Beat (Israel), VitalConnect (US), VivaLNK Inc. (US), Bardy Diagnsotics, Inc. (US), Biotronik SE & Co. KG (Germany), Alive Cor, Inc. (US), and iRhythm Technologies (US).
Research Coverage
• The report studies the remote patient monitoring market based on product, application, end user, and region
• The report analyzes factors (such as drivers, restraints, opportunities, and challenges) affecting the market growth
• The report evaluates the opportunities and challenges in the market for stakeholders and provides details of the competitive landscape for market leaders
• The report studies micro-markets with respect to their growth trends, prospects, and contributions to the total remote patient monitoring market
• The report forecasts the revenue of market segments with respect to five major regions

Key Benefits of Buying the Report:

The report will help the leaders/new entrants in this market with information on the closest approximations of the revenue numbers for the overall market and the sub-segments. This report will help stakeholders understand the competitive landscape and gain more insights to better position their businesses and plan suitable go-to-market strategies. The report also helps stakeholders understand the pulse of the medical exoskeleton market and provides them information on key market drivers, restraints, challenges, and opportunities.
This report provides insights into the following pointers:
• Analysis of key drivers (rise in the geriatric and medically underserved (especially rural) populations; the growing prevalence of chronic conditions; the benefits of telehealth and telemedicine owing to the current shortage of physicians and care personnel due to the pandemic; increasing investments in telehealth and RPM, and rising technological advancements in telecommunications), restraints (inadequate AI workforce and ambiguous regulatory guidelines for medical software), opportunities (role and impact of AI in remote patient monitoring market, high utility of RPM in combating infectious disease and epidemics), challenges (behavioral barriers, healthcare affordability, and the lack of awareness)
• Market Penetration: Comprehensive information on product portfolios offered by the top players in the remote patient monitoring market. The report analyzes this market by type, application, and end user.
• Service Enhancement/Innovation: Detailed insights on upcoming trends in the remote patient monitoring Market
• Market Development: Comprehensive information on the lucrative emerging markets type, application, end user.
• Market Diversification: Exhaustive information about new devices and software, growing geographies, recent developments, and investments in the remote patient monitoring Market
• Competitive Assessment: In-depth assessment of market shares, growth strategies, product offerings, company evaluation quadrant, and capabilities of leading players in the remote patient monitoring Market.

ページTOPに戻る

ご注文は、お電話またはWEBから承ります。お見積もりの作成もお気軽にご相談ください。

webからのご注文・お問合せはこちらのフォームから承ります

本レポートと同分野（医療/ヘルスケア）の最新刊レポート

MarketsandMarkets社のHealthcare IT分野での最新刊レポート

本レポートと同じKEY WORD（devices）の最新刊レポート

よくあるご質問

MarketsandMarkets社はどのような調査会社ですか?

マーケッツアンドマーケッツ（MarketsandMarkets）は通信、半導体、医療機器、エネルギーなど、幅広い市場に関する調査レポートを出版しています。また広範な市場を対象としたカスタム調査も行って... もっと見る

調査レポートの納品までの日数はどの程度ですか?

在庫のあるものは速納となりますが、平均的には 3-４日と見て下さい。
但し、一部の調査レポートでは、発注を受けた段階で内容更新をして納品をする場合もあります。
発注をする前のお問合せをお願いします。

注文の手続きはどのようになっていますか?

1)お客様からの御問い合わせをいただきます。
2)見積書やサンプルの提示をいたします。
3)お客様指定、もしくは弊社の発注書をメール添付にて発送してください。
4)データリソース社からレポート発行元の調査会社へ納品手配します。
5) 調査会社からお客様へ納品されます。最近は、pdfにてのメール納品が大半です。

お支払方法の方法はどのようになっていますか?

納品と同時にデータリソース社よりお客様へ請求書（必要に応じて納品書も）を発送いたします。
お客様よりデータリソース社へ（通常は円払い）の御振り込みをお願いします。
請求書は、納品日の日付で発行しますので、翌月最終営業日までの当社指定口座への振込みをお願いします。振込み手数料は御社負担にてお願いします。
お客様の御支払い条件が60日以上の場合は御相談ください。
尚、初めてのお取引先や個人の場合、前払いをお願いすることもあります。ご了承のほど、お願いします。

データリソース社はどのような会社ですか?

当社は、世界各国の主要調査会社・レポート出版社と提携し、世界各国の市場調査レポートや技術動向レポートなどを日本国内の企業・公官庁及び教育研究機関に提供しております。
世界各国の「市場・技術・法規制などの」実情を調査・収集される時には、データリソース社にご相談ください。
お客様の御要望にあったデータや情報を抽出する為のレポート紹介や調査のアドバイスも致します。

サマリー

目次

Summary

Table of Contents

ご注文は、お電話またはWEBから承ります。お見積もりの作成もお気軽にご相談ください。

本レポートと同分野（医療/ヘルスケア）の最新刊レポート

MarketsandMarkets社のHealthcare IT分野での最新刊レポート

本レポートと同じKEY WORD（devices）の最新刊レポート

よくあるご質問

MarketsandMarkets社はどのような調査会社ですか?

調査レポートの納品までの日数はどの程度ですか?

注文の手続きはどのようになっていますか?

お支払方法の方法はどのようになっていますか?

データリソース社はどのような会社ですか?